Cell replacement therapies offer promise in the treatment of neurotrauma and neurodegenerative disorders and have concentrated on the use of primary fetal brain tissue. However, there is a growing promise of using neural stem cells, in which case other factors may be important in their successful engraftment. We therefore investigated whether the co-expression of the major developmental transcription factor (Pax7 in this study) of donor tissue to graft site influences transplant survival and differentiation in the rat midbrain. Neural progenitor cells were prepared from either the Pax7 -expressing dorsal (DM) or non-Pax7 -expressing ventral mesencephalon (VM) of embryonic EGFP +/+ rats. Cells were dissociated and grafted into the adult rat superior colliculus (SC) lesioned with quinolinic acid 3 days previously, a time shown to be associated with the up-regulation of Pax7 . Grafts were then examined 4 weeks later. Our results suggest the origin of the graft tissue did not alter graft survival in the SC; however, dorsal grafts appear to have a higher incidence of neuronal survival, whereas ventral grafts have a higher incidence of astrocytic survivors.
Introduction
Cell replacement therapies present an appealing treatment option for a broad range of central nervous system (CNS) diseases/trauma, including Parkinson's disease and stroke (McKay, 1997; Gage, 2000; Lindvall & Kokaia, 2005; Kim, 2007) . Therapies are based on the concept that grafting of replacement cells, typically fetal neural tissue, can restore function (Freed et al. 1990; Barker, 2000; Bjorklund & Lindvall, 2000) and some clinical trials appear to support this notion (reviewed in Lindvall & Bjorklund 2004) . To date, the major approach has been to use stem/progenitor cells taken from differentiating regions of fetal brain (Ostenfeld et al. 1999; Hitoshi et al. 2002; Parmar et al. 2002; Hurelbrink & Barker, 2005) . Whereas even stem/progenitor cells can be coaxed into becoming the appropriate neurons in culture (Simon et al. 2003; Lyng et al. 2007 ), a similar outcome in vivo has been problematic (Svendsen et al. 1996; Lundberg et al. 1997; Barker & Dunnett, 1999; Mendez et al. 2005) .
One explanation for this is that conditions in vitro are relatively easy to define. In contrast, the host environment is fraught with a range of complicating factors, including the host inflammatory response, reactive gliosis and microglia activation, bringing in a range of inflammatory and neurotrophic factors (Stoll & Jander, 1999; Johann et al. 2007) . One area that is poorly studied is the influence of transcription factors that are expressed in these brain tissues. A host of studies have emphasized their importance for neural and glia specification during development and it is of interest to examine whether their expression is an influencing factor in tissue grafting (Yamamoto et al. 2001; Ojeda et al. 2003) .
Of particular interest are transcription factors that are considered to be master control genes. During development, finely tuned gene cascades are involved in the progressive differentiation of cells (Ericson et al. 1997; Wurst & Bally-Cuif, 2001 ). Many of these circuits, once initiated, operate as positive feedback loops (Joyner, 1996) . However, some genes have a more potent role in cellular differentiation than others -such as the gene at the apex of the cascade (Gehring, 1996) . The apical gene, or the 'master control' gene, by definition initiates and regulates the entire cascade of finely tuned downstream gene expression. We would suggest that by understanding the role of master control genes in cell transplant models, significant improvements could be made. Alternative approaches that concentrate on relatively subordinate gene(s) may be a less effective approach.
In this context Pax genes are of particular interest as they are considered to be master control genes. Pax genes encode for transcription factors that are highly conserved during evolution for the specification of neuronal and glial cells during brain development. Pax genes play fundamental roles in establishing the boundaries of the neural axes into specific regions and in specifying the different cell types within brain nuclei (Stoykova & Gruss, 1994; Chalepakis & Gruss, 1995) . Manipulation of Pax genes by gene mutation, gene misexpression or tissue transplantation has highlighted the ability of Pax genes to alter key developmental processes (Gehring, 1996; Mansouri et al. 1996; Nomura et al. 1998; Matsunaga et al. 2000) . Pax7 in particular is known to be functionally significant during midbrain development (Thompson et al. 2008) and is up-regulated in the injured adult CNS (Kawakami et al. 1997; Nomura et al. 1998; Thomas et al. 2007 ), thus we sought to investigate whether it was important in optimizing cell survival and graft integration.
In the present study, we wished to examine whether corresponding Pax7 expression profiles of graft and host brain tissues can influence the survival and differentiation of grafted tissues into the lesioned superior colliculus (SC). We take advantage of the fact that Pax7 expression is dichotomous in the embryonic midbrain, the precursor of the SC. Whereas the dorsal midbrain (DM) expresses Pax7 , the ventral midbrain (VM) does not (Kawakami et al. 1997) . As the lesioned SC also expresses Pax7 , it would be of interest to study the influence of Pax7 co-expression in donor (DM) and host (SC) tissues with respect to graft integration. As a control, donor tissue (VM) lacking Pax7 was used. Further controls included host tissue (adult striatum; ST) that does not express Pax7 engrafted with either DM expressing Pax7 or the VM lacking Pax7. The results showed that whereas Pax7 expression in donor tissue did not influence the number of surviving neurons, it was significantly correlated with a reduction in the number of surviving astrocytes, regardless of the grafted site (SC or ST). These results would point to the conclusion that whereas Pax7 expression per se is not a significant determinant of neuronal graft survival and integration, it appears to influence astrocytic survival.
Materials and methods

Surgery
Experimental procedures were in accordance with Institutional Ethics Committees (UK Animal (Scientific Procedures) Act 1986, and University of Western Australia Ethics Committees). SpragueDawley rats (200-250 g) were used. Surgery was conducted under halothane anaesthesia by inhalation. Unilateral lesions of the SC or ST were induced by injecting 0.5 µ L of a 0.09 M solution of quinolinic acid at pH 7.4 (Sigma, Australia). Co-ordinates for the SC were: anterior to bregma (A) − 6 mm, lateral to bregma (L) − 1 mm, and vertical below dura (V) − 3 mm (Paxinos & Watson, 1998) . Coordinates for the ST were: anterior to bregma (A) +1.2 mm, lateral to bregma (L) − 2.6 mm and vertical below dura (V) − 4.5 mm with the nose bar set at − 3.3 mm below the interaural line. Donor tissues for grafting were sourced from transgenic rats (Sprague-Dawley) at embryonic (E) day 14. This line of transgenic rat carries the enhanced green fluorescence protein (EGFP) reporter gene under the control of the cytomegalovirus (CMV) enhancer and the chicken β -actin promoter (Ito et al. 2001) . The DM and VM tissues were dissected from transgenic embryos, crude cell suspensions prepared, and the cells seeded at a density of 200 000 cells mL -1 in DMEM/ HAMS F12 medium (3 : 1 ratio). Media supplements include 2% B27, 1% penicillin/streptomycin/fungizone, human recombinant basic fibroblast growth factor, epidermal growth factor (both at 20 ng mL -1
) and heparin (5 µ g mL -1
) (Caldwell et al. 2001; Hurelbrink & Barker, 2005) . Cultures were maintained at 37 ° C in 95% air/ 5% CO 2 for 7 days, at which time EGPF+ progenitor cells were collected, dissociated and 250 000 cells placed in 2 µ L of grafting medium (DMEM, 0.001%DNAse) before being stereotactically injected into the SC or ST of recipient animals. In total, 20 animals were injected with grafts; five animals received DM cells into the SC; five animals received VM cells into the SC, five animals received DM cells into the ST; and five animals received VM cells into the ST (Fig. 1 ). Animals were sacrificed 4 weeks post-grafting for analysis.
Immunohistochemistry/immunofluorescence
Animals were given a lethal intraperitoneal injection of Euthatal (pentobarbitone sodium, 200 mg mL -1 , Sagatal, May and Baker), and transcardially perfused with 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4. Brains were removed, post-fixed in 4% paraformaldehyde overnight, transferred to 30% sucrose for a further 48 h and 50-µ M sagittal sections were cut using a freezing microtome. Sections were first treated with Tris buffered saline (TBS)/10% methanol/10% H 2 O 2 before being incubated in TBS/ 0.2% Triton-X100/5% normal goat serum and primary antibodies applied overnight at 4 ° C. Antibodies used were: Pax7 (1/10; mouse monoclonal; DSHB), NeuN (1/100; rabbit IgG; Abcam), GFAP (1/250; rabbit polyclonal; Abcam), and nestin (1/500; rabbit IgG; Abcam). Antibody binding was detected via biotinylated anti-mouse, or anti-rabbit IgG (1/200; Vector Laboratories) and either visualized using DAB (DAKO), or fluorescently using biotinylated goat anti-rabbit-IgG or biotinylated goat anti-mouse-IgG (1/200; Vector Laboratories) followed by streptavidin-AlexaFluor488, anti-mouseIgG-AlexaFluor546, or anti-rabbit-IgG-AlexaFluro546 (1/500; Invitrogen) and counterstained with Hoechst (Sigma). Sections were always run at the same times, and controls without primary antibody were negative and in all cases revealed no staining. Stained sections were visualized using a motorized Leica DM RB/E microscope and image capture and analysis programs I MAGE P RO P LUS and M ETA M ORPH 6.2. Confocal micrographs where obtained using CONFOCAL software and the BioRad MRC 1000 Confocal Laser Scanning Microscope.
Quantification and statistical analysis
Pax7 profile of the host SC The method of quantifying the total number of cells (cresyl violet positive) and the number of Pax7 + cells in the SC dorsal laminae has previously been described (Thomas et al. 2007) . Briefly, cells were counted in seven equally sized regions evenly distributed across the rostro-caudal axis (region #1 being the most rostral and region #7 the most caudal) and repeated on five sections selected from across the medial-lateral axis. This ensured that as the size of the SC varied along the medial-lateral axis, counts were performed in relatively equivalent position along the rostrocaudal axis. Counts for each rostro-caudal region were averaged, standard errors calculated, results plotted and a repeated measures 2-way ANOVA with the rostral-caudal region as the within-subject variable performed.
Graft outcomes. Graft outcomes were assessed in terms of graft survival as indicated by the presence or absence of EGFP cells. Scoring for graft survival was performed by stereological assessment of graft uptake using the following categories:
(1) total number of cells expressing EGFP, (2) number of cells expressing both EGFP and Pax7 (EGFP/Pax7), (3) number of cells expressing EGFP and the neuronal marker NeuN (EGFP/ NeuN), and (4) number of cells expressing EGFP and the astrocytic marker GFAP (EGFP/GFAP). The number of surviving cells containing EGFP were expressed as a percentage of total cells grafted (250 000), and EGFP/Pax7, EGFP/NeuN and EGFP/ GFAP were converted to percentages of surviving cells and analysed statistically using a 2-way ANOVA . For stereology, one in 12 sections was randomly assigned for counting and the number of grafted cells calculated using the Nv · Vref method (Gundersen et al. 1988 ). Due to the size and position of the SC, some neural cell grafts failed to remain within the SC and these animals were not considered.
Results
In vitro expression of Pax7 in cultured midbrain cells
Following 1 week in culture, DM and VM cells were assessed for Pax7 expression. The results showed that Pax7 was present in 42% of DM cells but only in 3% of VM cells (Table 1 ). The small quantity of Pax7 cells in VM cultures possibly reflects contamination by DM cells during dissection. Culture conditions for DM and VM cells were similar, and this is reflected in the similarities in nestin expression (52% for both DM and VM), representing undifferentiated cells in both pools ( P > 0.05, Table 1 ).
Pax7 expression in the SC and ST
The number of Pax7 + cells in the normal SC ( Fig. 2A) formed a shallow rostral low -caudal high gradient ( Fig. 2D ; P = 0.029).
However, 3 days post lesion (Fig. 2B ), Pax7 + cell numbers increased caudally, giving rise to a significantly steeper rostral low -caudal high gradient ( Fig. 2D ; P < 0.001). One month after the transplantation of cell grafts (Fig. 2C ), a rostral low -caudal high Pax7 gradient ( Fig. 2E ; P < 0.001) in the host SC was still significantly steeper than that observed in normal animals ( Fig. 2E ; P = 0.031). These results point to lesion-induced Pax7 expression, particularly in the caudal region of the SC. At no point (normal, injured or post-cell grafts) was Pax7 expression observed in cells of the host ST (results not shown).
Cell survival and Pax7 expression in grafts
To assess whether or not co-expression of Pax7 in the donor and host tissues is a key factor in graft survival, survival profiles of DM (Pax7 ) were compared (DM → SC and VM → SC respectively). In both groups, cells were present in at least four of the five experimental animals of both groups (Table 1) with all grafts having a similar appearance (Fig. 3) . The mean number of surviving cells was similar for both groups Neurosphere donor cells derived from either the DM or VM of embryonic day 14 EGFP +/+ rats were cultured for 1 week and the number of cells that expressed Pax7 assessed and expressed as a percentage. The Pax7 status of the host brain regions (SC or ST) were assessed before and after injection of the toxin quinolinic acid and assigned a ranking of either; no Pax7 expression (−), some Pax7 expression (+), and heightened levels of Pax7 expression (++). Having ascertained the initial Pax7 status, the influence of co-expressing Pax7 in both the donor and host on graft outcome was assessed. The orthologous transplantation group transplanted DM(Pax7 + ) into SC(Pax7 + ). Non-orthologous transplantation groups included: VM(Pax7 − ) into SC(Pax7 + ), DM(Pax7 + ) into ST(Pax7 − ) and VM(Pax7 − ) into ST(Pax7 − ). Five replicates were performed for each experimental group. The total number of surviving graft cells (EGFP + ) was determined and averaged to obtain the EGFP average (± standard error). Surviving EGFP + cells were also characterized for Pax7, NeuN or GFAP expression and the results converted to a mean percentage (± standard error) of those cells that survived. Finally the ratio of surviving cells that also co-expressed NeuN or GFAP was determined. In some cases, the neural cell grafts failed to remain within the SC, with EGFP + cells observed in the cavity between the SC and cortex; these cases were not considered for further analysis (as denoted by N/A in the table above).
(DM→SC: 4789 ± 1514 and VM→SC: 5197 ± 1495), representing a mean survival rate of 2%.
In the DM→SC group, the mean number of surviving cells that were EGFP (Table 1 ) with a mean number of surviving cells 32 931 ± 8305 (13%), which is higher than that observed in the SC grafts. The mean number of surviving cells that were EGFP + /Pax7 + was 4138 ± 83, representing overall 6 ± 0.3% of surviving cells (Fig. 4) . This difference in the number of surviving cells that were EGFP + /Pax7 + following transplantation of DM into the ST was significantly decreased compared to that seen when DM was transplanted into the SC (P < 0.001). Cell survival was significantly reduced in the VM→ST group with a mean number of surviving cells performed into the lesioned SC compared to the lesioned ST ( Fig. 4 ; Table 1 ).
Cellular fates of transplanted cells
In all four groups, the surviving cells contained neurons (NeuN + ) and astrocytes (GFAP + ) along with cells that remained negative for either marker (Fig. 3) .
There was no significant difference in the mean number of surviving cells that differentiated into neurons between the SC transplanted groups (Table 1 ). In the DM→SC and VM→SC groups, a mean of 2290 ± 1160 and 2676 ± 1213 of the cells that survived were EGFP + /NeuN + , representing overall 33 ± 5% and 40 ± 9% of surviving cells, respectively, with no statistical difference in the neuronal survival rate (P > 0.1). This lack of a significant difference in neuronal survival between DM and VM cells transplanted into the SC was also reflected in the DM and VM cells transplanted into the ST. In these latter groups, the DM→ST had a mean number of 7512 ± 2434, which represented 18 ± 3% of surviving cells that were EGFP In contrast, there appeared to be a difference in the number of surviving astrocytes that is correlated with the presence or absence of Pax7 expression in the donor. In − grafted tissue (VM→SC), which had a mean survival number of astrocytes at 2097 ± 1017 (68 ± 20%). Statistical analysis indicated significant differences between the two groups (P < 0.05). This correlation between a reduction in astrocytic survival and the presence of Pax7 in the graft is maintained even in the DM→ST and VM→ST groups (2752 ± 594 or 12 ± 3%, and 294 ± 144 or 24 ± 6%, respectively). Thus, it would appear that the presence of Pax7 in the grafted cells, regardless of the identity of the host tissues, is influential in reducing the number of surviving astrocytes.
Discussion
This study was designed to explore whether expression of the master control gene, Pax7, in donor and host tissues has a significant effect on neuronal and astrocytic survival. This question has implications for designing cell replacement therapies for CNS disorders. Our results indicate that co-expression of Pax7 in grafted cells and donor tissue is associated with reduced astrocytic numbers.
Pax7 expression status of the surviving graft cells reflects that of the host brain region
Regardless of the origin and initial Pax7 expression profile of the grafted tissue following transplantation, the majority of the surviving cells reflected that of the host brain region. Thus both DM and VM grafts into the Pax7-expressing SC resulted in a much higher percentage of surviving cells being Pax7 + (over 50%) compared to the initial graft percentages. Upon transplantation into the non-Pax7-expressing ST the percentage of surviving DM and VM graft cells that expressed Pax7 was significantly reduced (less than 25%) compared to the initial graft percentages. This alteration in overall Pax7 composition of the grafts suggests that the graft cells are reprogrammed in the lesion environment. In terms of the SC grafts, the increased Pax7 expression of donor cells may be a response to the up-regulation of Pax7 in the injured host environment. Deafferentation of the SC results in an increase in the number of Pax7 + cells in the SC sgfs laminae (Thomas et al. 2007 ), and we can now extend these findings to show that there is a rapid increase in Pax7-expressing cells when the SC is directly lesioned with quinolinic acid. The short time frame (3 days) indicates that in these cells Pax7 expression is up-regulating rather than new Pax7 + cells being generated. The current study also reinforces the notion that following injury, the adult SC may recruit developmental cues (Yamamoto et al. 2001; Rossi et al. 2007 ). In the present work, Pax7 expression levels remain elevated in the SC with a significant rostral 
Matching Pax7 expression of the graft cells and host brain region correlates to a greater proportion of neurons compared to glia
Our results indicate that initial Pax7 expression in the graft (DM→SC and DM→ST) has a strong effect in influencing a greater percentage of neuronal survival, compared to glia. This effect is observed irrespective of whether the host site is orthologous (SC) or non-orthologous (ST). This property is in accord with previous studies demonstrating the important role of Pax7 in midbrain regionalization and subsequent differentiation, in addition to adult neuron expression of Pax7 (Thomas et al. 2007 ). The ability of Pax7 to regulate neurogenesis has previously been demonstrated in vitro, where ectopic expression of Pax7 in embryonal carcinoma P19 cells resulted in all of the cells undergoing neural differentiation (Ziman et al. 2001; Thomas et al. 2004 ).
In contrast with neurons, the absence of Pax7 in donor tissues (VM) is strongly correlated with an increased proportion of surviving glial cells. This outcome was observed whether VM tissue was grafted into SC or ST, indicating that it is an intrinsic rather than an extrinsic property. The exact reason for increased glial survival remains unclear but there are a number of possibilities. First, the absence of Pax7 may have coaxed uncommitted progenitor cells into the glial lineage. Secondly, the failure of grafted neurons to survive, due to the absence of Pax7 expression, may have reciprocally encouraged grafted glial progenitors to survive and expand. In this context, the results of the present study may provide important lessons for future cell replacement strategies. For example, it is worth noting that astrocytes are important support cells for neurons as well as being influential in directing neural differentiation (Hall et al. 2003) . However, too many astrocytes result in scar formation. Depending on the disease/injury situation, it will be important to achieve an appropriate balance. Of equal importance will be to further characterize the graft cells. As the graft cells utilized in these experiments were derived from EGFP animals (to enable their distinction from the host cells) triple labelling will be necessary. It will be of importance to determine whether all Pax7-expressing cells are neurons or astrocytes. Likewise, as not all of the surviving graft cells express Pax7, or markers for neurons or astrocytes, it will be important to determine whether they remain as progenitor cells or have differentiated into other cell types such as microglia.
Grafts into the adult brain respond differently than those in the embryonic brain
There is a discrepancy between our transplantation experiments in the adult CNS compared to those in the embryonic CNS. Our results demonstrated that following transplantation the Pax7 status of the grafted cells reflected that of the host brain region (Fig. 4) . In the developing CNS, similarly to our VM→SC transplantation group, when non-Pax7-expressing lateral prosencephalon tissue was transplanted into Pax7-expressing dorsal mesencephalon, the grafted tissue was induced to express Pax7 (Nomura et al. 1998 ). However, in contrast to our DM→ST group, when Pax7-expressing embryonic DM tissue was grafted into the developing non-Pax7-expressing prosencephalon, the grafted tissue continued to express Pax7 (Nomura et al. 1998) . If in the adult CNS, the master control gene (in this scenario, Pax7) for the differentiation of a specific type of cell is switched off in the grafted cells, so too is the ability of the cells to continue differentiate into their 'pre-determined' fate. These findings have significant implications in the design of cell replacement therapies.
Developmental role points to the importance of Pax7
To date, the reason for continued Pax expression in terminally differentiated adult CNS cells, as well as the increase in expression of Pax genes specifically in cells derived from those that expressed the Pax gene during development following indirect or direct (this study) injury to the adult CNS, remains to be elucidated. It is known, however, that Pax genes have the ability to initiate and control entire differentiation processes, so much so that they have been termed 'master control genes'. For example ectopic Pax6 expression on the wing or leg of Drosophila results in the formation of an entire eye (Gehring, 1996) ; formation of the midbrain superior colliculus/tectum always correlates with Pax7 expression (Nomura et al. 1998; Matsunaga et al. 2001) . Developmentally, the segmented expression of Pax genes in response to secreted local cues is considered to play an intrinsic role in CNS regionalization and at later stages in the specification of specific subtypes of cells. While other factors are important, by definition, combined with the importance of Pax genes during development, we anticipate that Pax7 must be high up in the hierarchy of events that are responsible for the reduced gliogenesis observed in these experiments. However, to validate the role of Pax7 it will be necessary to transplant homogeneous populations of Pax7-expressing DM and non-Pax7-expressing VM. We initially attempted to isolate these populations by fluorescent activated cell sorting (FACS). However, as Pax7 is a transcription factor and not present on the cell surface, utilization of FACS resulted in cell damage and reduced survival in vitro. Our current experiments are now focused on overexpressing and inhibiting Pax7 expression in the graft cell populations.
In summary, the results of this proof-of-principle study demonstrate that co-expression of Pax7 in the graft cells and the host environment is a strong determinant of graft survival and differentiation. The matching of donor and host tissue are important parameters, and a prior knowledge of transcription factor expression, particularly those factors considered to be master control genes, needs to be considered whether graft outcomes are biased in favour of neurons or of astrocytes.
